Related Experiment Video
Updated: Aug 20, 2026

Postmortem Diagnosis of Rabies in Animals by the Updated, Multiplexed LN34 Real-Time Reverse Transcription-Polymerase Chain Reaction Assay
Published on: May 2, 2025
Quantitation of defective and ecotropic viruses during LP-BM5 infection by real time PCR and RT-PCR
Andrea Paun1, Kathryn Shaw, Scott Fisher
1Discipline of Microbiology, School of Biological and Chemical Sciences, The University of Western Australia, Nedlands, WA 6009, Australia.
Abstract:
Murine AIDS (MAIDS) is a pathology induced by the LP-BM5 murine leukaemia virus mixture in susceptible strains of mice such as C57BL/6J resulting in lymphoproliferation and progressive immunodeficiency. The etiologic agent of this pathology is BM5d, a replication defective virus. BM5e is a replication competent virus in the viral mixture that functions as a helper virus. This paper describes real time PCR and RT-PCR assays for quantitation of the proviral DNA and viral RNA of BM5d and BM5e. Data is presented describing the change in BM5d and BM5e proviral DNA levels and viral RNA levels in both blood and spleen in the first 8 weeks of infection. Infected mice have increasing levels of BM5d and BM5e viral DNA and RNA detectable from as early as 2 weeks post infection. Similar levels of proviral DNA was found for BM5d and BM5e in PBMC and spleen, however higher levels of BM5e viral RNA were observed in both tissues throughout infection. The assays described can be used as both a diagnostic tool and to investigate the direct effect of treatments on the BM5d and BM5e viruses and MAIDS development.
Insights
New real-time PCR assays quantify Murine AIDS (MAIDS) viral components, BM5d and BM5e. These methods track viral load in mice, aiding MAIDS research and treatment evaluation.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Murine AIDS (MAIDS) is a T-cell immunodeficiency induced by the LP-BM5 retroviral mixture in mice.
- The LP-BM5 mixture contains a replication-defective virus (BM5d) and a replication-competent helper virus (BM5e).
- Accurate quantification of viral components is crucial for understanding MAIDS pathogenesis and evaluating therapeutic interventions.
Purpose of the Study:
- To develop and validate real-time PCR and RT-PCR assays for quantifying BM5d and BM5e proviral DNA and viral RNA.
- To monitor the dynamic changes in viral loads in blood and spleen during the early stages of MAIDS infection.
- To establish a quantitative tool for MAIDS research and treatment assessment.
Main Methods:
- Development of real-time quantitative PCR (qPCR) for proviral DNA detection.
- Development of real-time quantitative reverse transcription PCR (qRT-PCR) for viral RNA detection.
- Application of these assays to quantify BM5d and BM5e in blood (PBMC) and spleen of infected C57BL/6J mice over 8 weeks.
Main Results:
- Real-time PCR and RT-PCR assays successfully quantified BM5d and BM5e DNA and RNA.
- Viral DNA and RNA were detectable as early as 2 weeks post-infection and increased over time.
- Similar proviral DNA levels for BM5d and BM5e were observed in PBMCs and spleen.
- Higher viral RNA levels of BM5e compared to BM5d were detected in both tissues throughout the infection period.
Conclusions:
- The developed real-time PCR and RT-PCR assays are effective tools for quantifying MAIDS-associated viruses.
- These assays provide valuable insights into the viral kinetics during MAIDS progression.
- The quantitative data can facilitate the evaluation of antiviral strategies and the study of MAIDS pathogenesis.
More Related Videos
08:36Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Published on: November 1, 2018
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011